Dr. James Christopher Dean, MD

Dr. Dean practices at Eye Care Northeast Surgical Partners LLC in Putnam, Connecticut.

Dr. Dean's NPI, 1083618532, was assigned on June 10, 2005. Dr. Dean graduated from Boston University School Of Medicine in 1987. Dr. Dean holds Connecticut license 033374.

Dr. Dean's primary practice is Eye Care Northeast Surgical Partners LLC, at 5 Kennedy Dr, Putnam, CT 06260 in Northeastern Ct County. The practice phone is (860) 928-0414.

Dr. Dean's primary practice is Eye Care Northeast Surgical Partners LLC in Putnam, Connecticut. Dr. Dean is also affiliated with Day Kimball Hospital. Dmand AI also links Dr. Dean to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dean practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Dean's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dmand AI has Dr. Dean's licenses on file in 2 states: Connecticut and Michigan.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Dean treats.

CMS data shows 5,180 Medicare services from Dr. Dean across 27 procedure codes in 2024, for 1,399 Medicare patients. Medicare paid $541,702 for them.

CMS counts 1,399 Medicare patients who saw Dr. Dean in 2024. The largest group is 75 to 84, with 578 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dean's median patient age at 74, with 56% women.

In 2024, Dr. Dean wrote 5,200 Medicare Part D claims for 1,138 patients. 55% of them were for generic drugs. CMS names the drug for 5,094 of them, across 32 drugs with 11 or more claims each, at $754,526 in total drug cost. In 2023, CMS named 4,997 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Dean for performance year 2024, reported as part of a group. Dr. Dean accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 387 procedures of cataract surgery by Dr. Dean, more than 93% of the clinicians it reports for that procedure.

CMS Open Payments shows 414 general payments to Dr. Dean from 33 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 59% of the total. RxSight Inc paid the most, $19,409.

Dmand AI lists 1 award for Dr. Dean.

Dr. Dean graduated from Boston University School Of Medicine in 1987. Dr. Dean is a member of AAO.

Dr. Dean is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.